Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Prevention of hypokalemia in patients receiving diuretics or corticosteroids. ## Adult Dosing * **Oral:** * Prevention: 20 mEq (1.5 g) once daily. * Treatment: 40-100 mEq (3-7.5 g) per day divided into 2-5 doses. Specific dosing depends on serum potassium levels and clinical status. * Maximum oral dose: Generally not to exceed 200 mEq (15 g) per day, but careful titration based on potassium levels is crucial. * **Intravenous (IV):** * For treatment of hypokalemia when oral administration is not feasible or when rapid correction is needed. * Concentration and rate of infusion are critical to avoid cardiac arrhythmias and local irritation. * **Mild hypokalemia (3.0-3.4 mEq/L):** 20-40 mEq (1.5-3 g) infused over several hours. * **Moderate hypokalemia (2.5-2.9 mEq/L):** 40-80 mEq (3-6 g) infused over several hours. * **Severe hypokalemia (<2.5 mEq/L):** May require higher doses, potentially up to 200 mEq (15 g) per 24 hours, administered in a monitored setting (e.g., ICU). * **Maximum IV infusion rate:** Generally no faster than 10-20 mEq/hour (0.75-1.5 g/hour) peripherally. Central line administration may allow for faster rates (up to 40 mEq/hour or 3 g/hour) in critical, monitored situations. Dosing and rate depend heavily on local protocol and patient monitoring. ## Pediatric Dosing * Dosing is weight-based and depends on serum potassium levels and clinical status. * **Oral:** Typical maintenance: 1-2 mEq/kg/day (0.075-0.15 g/kg/day) divided into 1-4 doses. * **Intravenous (IV):** Dosing and infusion rates require careful calculation and continuous cardiac monitoring. Maximum recommended daily dose is typically 3 mEq/kg/day (0.225 g/kg/day). Infusion rates should generally not exceed 0.3-0.5 mEq/kg/hour (0.0225-0.0375 g/kg/hour). Specific protocols should be followed. ## Dose Adjustments * Renal impairment: Reduce dose significantly. Use with extreme caution in severe renal impairment. * Monitor serum potassium closely. ## Contraindications * Hyperkalemia. * Conditions causing increased potassium levels, such as severe renal impairment, untreated Addison's disease, acute dehydration, strenuous muscle exertion, extensive tissue injury, or certain drug therapy (e.g., potassium-sparing diuretics, ACE inhibitors, ARBs, NSAIDs). * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence. * **Serious:** Hyperkalemia (arrhythmias, muscle weakness, paresthesia, cardiac arrest), gastrointestinal ulceration, bleeding, or perforation. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Increased risk of hyperkalemia. * **NSAIDs:** May reduce potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hypokalemia can increase the risk of digoxin toxicity; conversely, hyperkalemia can reduce its efficacy. * **Anticholinergics:** May slow gastrointestinal transit, increasing the risk of localized GI irritation or erosion with oral solid dosage forms. ## Monitoring * Serum potassium levels (frequently, especially with IV therapy or dose adjustments). * Renal function (BUN, creatinine). * Electrocardiogram (ECG), particularly during IV infusion or if hyperkalemia is suspected. * Signs and symptoms of hypokalemia or hyperkalemia. ## Clinical Pearls * Oral liquid formulations or effervescent tablets are often preferred over solid tablets to minimize gastrointestinal irritation. If solid tablets are used, advise patients to take with ample fluid. * IV potassium should always be diluted and administered with caution due to the risk of fatal hyperkalemia and cardiac arrest. Never administer as an IV bolus. * Hypokalemia is often multifactorial; address the underlying cause if possible. * Be aware of non-prescription sources of potassium that can contribute to hyperkalemia (e.g., salt substitutes). *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always verify current prescribing information with the official product labeling and consult with appropriate healthcare providers for patient-specific recommendations.